Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma

Published:2021-06-18 Issue:24 Volume:100 Page:e26377
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Özdirik Burcin,Jost-Brinkmann Fabian,Savic Lynn Jeanette,Mohr Raphael,Tacke Frank,Ploner Christoph J.,Roderburg Christoph,Müller Tobias

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference23 articles.

1. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine;Fujiwara;J Hepatol,2018

2. Hepatocellular carcinoma;Forner;Lancet,2018

3. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2012

4. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma;J Hepatol,2018

5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature review;Journal of Cancer Research and Clinical Oncology;2024-08-24

2. Unravelling the Acute, Chronic and Steroid-Refractory Management of High-Grade Neurological Immune-Related Adverse Events: A Call to Action;Brain Sciences;2024-07-29

3. Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature review;2024-07-19

4. Systemic therapies in hepatocellular carcinoma: A revolution?;United European Gastroenterology Journal;2024-01-24

5. A Case of Patient with Atezolizumab-induced Encephalitis in Hepatocellular Carcinoma;Internal Medicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3